Saturday, January 25th, 2020
Home >> Med Devices,Women's Health News >> FDA: Birth Control Options
Essure coils in place, from Facebook

Essure coils in place, from Facebook

Women’s Health Litigation, August 22, 2016~ 

The U.S. Food and Drug Administration has issued a guideline for birth  control options.  “No one product is best for everyone,” it says.

It does not mention that there is litigation involving Yaz and Yasmin, Essure sterilization, NuvaRing and some forms of IUDs.  Please note that sterilization is intended to be permanent and may not be able to be removed.

There is growing litigation involving the Essure Problems and many unhappy women have formed a Facebook page.  See it here:

Essure even has its own page within the FDA. Last September, 2015, the FDA gathered a panel of experts to determine why so many women are having complications.   Here is the FDA page that summarizes their findings.  Bayer, the manufacturer, must undergo post-market surveillance of Essure.

Essure coils

Essure coils removed

Post-market means after it is already implanted in a woman’s body.

“Reported adverse events include persistent pain, perforation of the uterus and/or fallopian tubes, intra-abdominal or pelvic device migration, abnormal or irregular bleeding, and allergy or hypersensitivity reactions. Some women have had surgical procedures to remove the device. In addition, Essure failure, and, in some cases, incomplete patient follow-up, have resulted in unintended pregnancies.”

The FDA’s page for birth control devices is here:

Read more about Women’s Health Litigation here.  

the author

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.